Item 1.01. | Entry into a Material Definitive Agreement. |
Merger Agreement
On December 19, 2024, CCC Intelligent Solutions Holdings Inc. (“CCC” or the “Company”), CCC Intelligent Solutions Inc., a Delaware corporation and an indirect, wholly owned subsidiary of CCC (“CCCIS”), Edison Merger Sub I Inc., a Delaware corporation and a direct, wholly owned subsidiary of CCCIS (“Merger Sub I”), Edison Merger Sub II, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of CCCIS (“Merger Sub II”), EvolutionIQ Inc., a Delaware corporation (“EvolutionIQ”), and Shareholder Representative Services LLC, a Colorado limited liability company solely in its capacity as the representative, agent and attorney-in-fact of the EvolutionIQ equityholders, entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”).
Merger Structure
Pursuant to the terms of the Merger Agreement, (a) Merger Sub I will be merged with and into EvolutionIQ, pursuant to which the separate corporate existence of Merger Sub I will cease, and EvolutionIQ will continue as the surviving corporation and as a direct, wholly owned subsidiary of CCCIS (in such capacity, EvolutionIQ is sometimes referred to herein as the “First Step Surviving Corporation”) (the “First Merger”) and (b) immediately after the First Merger, the First Step Surviving Corporation will merge with and into Merger Sub II, pursuant to which the separate corporate existence of the First Step Surviving Corporation will cease, and Merger Sub II will continue as the surviving entity and as a direct, wholly owned subsidiary of CCCIS (the “Second Merger” and collectively with the First Merger, the “Merger”).
Merger Consideration
Upon consummation of the transactions contemplated by the Merger Agreement (the “Closing”), each share of EvolutionIQ capital stock issued and outstanding and each EvolutionIQ vested option that is outstanding and unexercised will be cancelled in exchange for aggregate consideration of $730 million, subject to certain adjustments (the “Total Merger Consideration”), which will consist of (a) approximately 59.5% in cash (the “Cash Consideration”) and (b) approximately 40.5% in shares of the Company’s common stock (the “Stock Consideration”) to be calculated based on a floating exchange ratio using the volume-weighted average price of the Company’s common stock for the 9-trading day period (as may be adjusted) ending on and including the trading day prior to the date of the Closing (subject to a 15% collar relative to the volume weighted-average price of the Company’s common stock for the 10-trading day period ending on and including the date of the Merger Agreement); provided that (i) the EvolutionIQ equityholders who are not accredited investors will receive all of their merger consideration in cash, (ii) the Stock Consideration issued to certain members of EvolutionIQ management and representing 40.5% of their respective total consideration will be subject to vesting requirements and transfer restrictions such that (x) 50% will vest on the first anniversary of Closing and (y) the remaining 50% will vest on the second anniversary of Closing, and (iii) the relative portions of the Cash Consideration and the Stock Consideration may be subject to adjustments based on a formula set forth in the Merger Agreement if the Stock Consideration represents less than 40.5% of the transaction consideration (based on the numerical average of the high and low trading prices for the Company’s common stock on the date of the Closing).
In addition to the aggregate consideration payable in exchange for EvolutionIQ capital stock and vested options, each EvolutionIQ unvested option and restricted stock award will be cancelled and exchanged into the Company’s restricted stock units or restricted stock, respectively, with equivalent value and substantially the same vesting schedule; provided that certain members of EvolutionIQ management will forfeit a portion of their unvested options.
Closing Conditions
Consummation of the Merger is subject to customary closing conditions, including (a) the absence of any law or order preventing or making illegal the consummation of the Merger, (b) the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), which has already expired, (c) approval from EvolutionIQ stockholders, which has already been obtained, and (d) only with respect to the Company’s obligations to consummate the Merger, absence of material adverse effect on EvolutionIQ.